LBG Joins Effort to Overcome the Challenges of Gene Therapy
Dr. Joe Rininger, Director, Cell and Gene Therapy, and Frank Orlowski, Director, Business Development, will attend Gene Therapy for Rare Disorders 2022 on March 7 – 10 at the Hynes …
News
LBG Joins Global Discussion to “Advance the Next Pillar of Medicine”
Dr. Jim Beltzer, Principal Consultant, Cell and Gene Therapy, and Frank Orlowski, Director, Business Development, will attend Advanced Therapies Week 2022, presented by Phacilitate, on January 25 – 28. As attendees, they will have the …
LBG Team members attend Microbiome Connect: Gut Therapeutics
Will Waterfield, Principal Consultant, Sayan Paria, Associate Consultant, and Hisham Nachabe, Analyst, will attend Microbiome Connect: Gut Therapeutics, a conference that provides a forum for professionals who are actively seeking …
Marco Daoura Attends HLTH 2021
Marco Daoura, Principal (Strategic Consulting, Medical Devices, Digital Health and HealthIT), will attend HLTH 2021 on October 17 – 20 at the Boston Convention & Exhibition Center. His attendance at …
Dr. Robert Huebner Speaks at BioKansas Community Forum
LBG is pleased to announce that Dr. Bob Huebner, Principal Consultant, will participate in a panel at BioKansas’ Community Forum entitled “Accelerating Biologics: The Market Landscape and Engineering Advancements” on …
BioProcess Insider State of the Industry
LBG would like to congratulate Dr. Josh Speidel, who was invited to participate in the BioProcess Insider State of the Industry webcast on September 15! Chosen for his expertise, Dr. …
Latham BioPharm Group Article Wins BPI Readers’ Choice Award!
“Each year BioProcess International publishes over 150 technical and scientific articles focusing on the latest science, technologies, and techniques supporting biopharmaceutical research, development, and manufacturing.” BioProcess International, Your Choices for BPI’s Best …
Pandemic Preparedness and Response Panel
Sponsored by Center for Entrepreneurship, in partnership with the College of Arts and Sciences Department of Biology, Corporate Engagement Office, and TechGROWTH Ohio. November 18, 2020 Robert Huebner, a Principal …
Life Sciences Fueling Purposeful Innovation
Sponsored by Independence Blue Cross & B. PHL Innovation Fest Presented by Venture Café Philadelphia LBG’s Gervan Williams joined a diverse panel of experts to discuss emerging opportunities for innovators, investors, …
Determining disease severity in patients with COVID-19
Timothy Alcorn co-authored a paper published by Lab on a Chip titled, “Clinical decision support tool and rapid point-of-care platform for determining disease severity in patients with COVID-19†”. Dr. Alcorn …